Amgen Inc. (NASDAQ:AMGN) is seeing shares trade up another 2% pre-market after yesterday’s decision where an FDA panel rejected a proposal to set a specific target for red blood-cell levels in kidney-failure…
We are frequently asked about how certain basket picks perform compared to the overall market. It has been years since anyone has claimed their stocks should gain regardless of the market because…
If you ever heard the old saying "Be careful what you wish for, you may get it!" it sure seems like we are there. It also makes you wonder if it is…
According to Reuters, Countrywide (CFC) will eliminate 900 jobs. Reuters writes that Apple (AAPL) is looking for higher sales and Europe launch of the iPhone as part of the reason it cut…
After reports last week that drug-coated stents posed little risk to heart patients, a new survey shows that "patients given drug-coated stents after an acute heart attack are nearly five times more…
Last week was a light volume trading week, but the markets were open and they didn’t wait for the holiday crowd to come back. Here is a snippet of some of the…
http://www.bloomberg.com/apps/news?pid=20601087&sid=ajZ2lVrqeb2I&refer=homeA study out fo Sweden may help the flagging fortunes of the stent businesses at Boston Scientific (BSX) and Johnsohn & Johnson (JNJ). Several pieces of research had indicated that drug-coated stents…
According to Reuters, HSBC (HBC) bought 51% of Korea Exchange Bank $6.3 billion. Reuters writes GE (GE) bought buy British oilfield services firm Sondex for $583 million. Reuters reports that oil moved…
Add to the poison pet food, toothpaste, and ten million lead-laden toys a new and dangerous product out of China. Johnson & Johnson (JNJ) has found counterfeit versions of its OneTouch Test…
Douglas A. McIntyre The DJIA is down more than another 150 points today, although it had been down 200 in pre-market activity before the Fed added liquidity this morning. We have been down actually less…
(ADTN) Adtran $0.28 EPS versus $0.28 estimate.(AIZ) Assurant CEO and CFO received SEC WELLS NOTICE.(ASD) American Standard noted as a positive ahead of split-up by Cramer on MAD MONEY.(CVO) Cenveo is acquiring…
Johnson & Johnson’s (JNJ) revenue rose 13% to $15.1 billion in Q2. However, if revenue from the purchase of Pfizer’s consumer healthcare business was accounted for, the topline would have been up…
Douglas A. McIntyre Imagine that if an aspirin did not get rid of you headache. And, the company that made the pain killer gave you your money back. A new proposal by Johnson & Johnson…
MONDAYMattel (NYSE:MAT)Novellus (NASDAQ:NVLS)Philips Electronics (NYSE:PHG/ADR)W.W. Grainger (NYSE:GWW) TUESDAYJohnson & Johnson (NYSE:JNJ)Intel Corporation (NASDAQ: INTC)Merrill Lynch (NYSE:MER)Novartis (NYSE:NVS/ADR)Pharmaceutical Product Development (NASDAQ:PPDI)SLM Corp. (NYSE:SLR)State Street (NYSE:STT)Coca Cola (NYSE:KO)Wells fargo (NYSE:WFC)Yahoo! (NASDAQ:YHOO) WEDNESDAYAbbott Labs (NYSE:ABT)Altria…
Not many hours after Johnson & Johnson (JNJ) announced its $10 billion share buy-back, ConocoPhillips (COP) decided it would not be bested. It announced a $15 billion share repurchase program of its…